The Role of Pyruvate Kinase M2 in Cancer Metabolism

Brain Pathology

Volumn 25, Issue 6, 2015, Pages 781-783

  Liu, Vivian M ^a,b   Vander Heiden, Matthew G ^a,c  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

cancer metabolism; glycolysis; pyruvate kinase M2

Indexed keywords

PYRUVATE KINASE; PYRUVATE KINASE M2; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ARTICLE; BREAST CANCER; CANCER METABOLISM; CELL PROLIFERATION; ENZYME KINETICS; GENE MUTATION; GLIOBLASTOMA; GLIOMA; GLUCOSE METABOLISM; HUMAN; METABOLISM; NONHUMAN; NUCLEOTIDE METABOLISM; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR GROWTH; ANIMAL; BRAIN TUMOR;

ANIMALS; BRAIN NEOPLASMS; GLIOMA; HUMANS; PYRUVATE KINASE;

EID: 84946230375     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/bpa.12311     Document Type: Article

References (39)

1. Anastasiou D, Poulogiannis G, Asara JM, Boxer MB, Jiang J, Shen M, et al (2011) Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses. Science 334: 1278-1283.
2. Anastasiou D, Yu Y, Israelsen WJ, Jiang J-K, Boxer MB, Hong BS, et al (2012) Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis. Nat Chem Biol 8: 839-847.
3. Ashizawa K, McPhie P, Lin KH, Cheng SY, (1991) An in vitro novel mechanism of regulating the activity of pyruvate kinase M2 by thyroid hormone and fructose 1, 6-bisphosphate. Biochemistry 30: 7105-7111.
4. Chaneton B, Hillmann P, Zheng L, Martin ACL, Maddocks ODK, Chokkathukalam A, et al (2012) Serine is a natural ligand and allosteric activator of pyruvate kinase M2. Nature 491: 458-462.
5. Christofk HR, Vander Heiden MG, Wu N, Asara JM, Cantley LC, (2008a) Pyruvate kinase M2 is a phosphotyrosine-binding protein. Nature 452: 181-186.
6. Christofk HR, Vander Heiden MG, Harris MH, Ramanathan A, Gerszten RE, Wei R, et al (2008b) The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 452: 230-233.
7. Cortés-Cros M, Hemmerlin C, Ferretti S, Zhang J, Gounarides JS, Yin H, et al (2013) M2 isoform of pyruvate kinase is dispensable for tumor maintenance and growth. Proc Natl Acad Sci U S A 110: 489-494.
8. Dombrauckas JD, Santarsiero BD, Mesecar AD, (2005) Structural basis for tumor pyruvate kinase M2 allosteric regulation and catalysis. Biochemistry 44: 9417-9429.
9. Eigenbrodt E, Reinacher M, Scheefers-Borchel U, Scheefers H, Friis R, (1992) Double role for pyruvate kinase type M2 in the expansion of phosphometabolite pools found in tumor cells. Crit Rev Oncog 3: 91-115.
10. Gao X, Wang H, Yang JJ, Liu X, Liu Z-R, (2012) Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase. Mol Cell 45: 598-609.
11. Gui DY, Lewis CA, Vander Heiden MG, (2013) Allosteric regulation of PKM2 allows cellular adaptation to different physiological states. Sci Signal 6: pe7.
12. Hitosugi T, Kang S, Vander Heiden MG, Chung T-W, Elf S, Lythgoe K, et al (2009) Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth. Sci Signal 2: ra73.
13. Hosios AM, Fiske BP, Gui DY, Vander Heiden MG, (2015) Lack of evidence for PKM2 protein kinase activity. Mol Cell 59: 850-857.
14. Imamura K, Tanaka T, (1972) Multimolecular forms of pyruvate kinase from rat and other mammalian tissues. I. Electrophoretic studies. J Biochem (Tokyo) 71: 1043-1051.
15. Israelsen WJ, Dayton TL, Davidson SM, Fiske BP, Hosios AM, Bellinger G, et al (2013) PKM2 isoform-specific deletion reveals a differential requirement for pyruvate kinase in tumor cells. Cell 155: 397-409.
16. Jiang Y, Li X, Yang W, Hawke DH, Zheng Y, Xia Y, et al (2014) PKM2 regulates chromosome segregation and mitosis progression of tumor cells. Mol Cell 53: 75-87.
17. Keller KE, Tan IS, Lee Y-S, (2012) SAICAR stimulates pyruvate kinase isoform M2 and promotes cancer cell survival in glucose-limited conditions. Science 338: 1069-1072.
18. Kung C, Hixon J, Choe S, Marks K, Gross S, Murphy E, et al (2012) Small molecule activation of PKM2 in cancer cells induces serine auxotrophy. Chem Biol 19: 1187-1198.
19. Lunt SY, Muralidhar V, Hosios AM, Israelsen WJ, Gui DY, Newhouse L, et al (2015) Pyruvate kinase isoform expression alters nucleotide synthesis to impact cell proliferation. Mol Cell 57: 95-107.
20. Lv L, Li D, Zhao D, Lin R, Chu Y, Zhang H, et al (2011) Acetylation targets the M2 isoform of pyruvate kinase for degradation through chaperone-mediated autophagy and promotes tumor growth. Mol Cell 42: 719-730.
21. Maher EA, Marin-Valencia I, Bachoo RM, Mashimo T, Raisanen J, Hatanpaa KJ, et al (2012) Metabolism of [U-13C]glucose in human brain tumors in vivo. NMR Biomed 25: 1234-1244.
22. Marin-Valencia I, Yang C, Mashimo T, Cho S, Baek H, Yang X-L, et al (2012) Analysis of tumor metabolism reveals mitochondrial glucose oxidation in genetically diverse human glioblastomas in the mouse brain in vivo. Cell Metab 15: 827-837.
23. Mazurek S, (2011) Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells. Int J Biochem Cell Biol 43: 969-980.
24. Morfouace M, Lalier L, Oliver L, Cheray M, Pecqueur C, Cartron P-F, Vallette FM, (2014) Control of glioma cell death and differentiation by PKM2-Oct4 interaction. Cell Death Dis 5: e1036.
25. Morgan HP, O'Reilly FJ, Wear MA, O'Neill JR, Fothergill-Gilmore LA, Hupp T, Walkinshaw MD, (2013) M2 pyruvate kinase provides a mechanism for nutrient sensing and regulation of cell proliferation. Proc Natl Acad Sci U S A 110: 5881-5886.
26. Muirhead H, Clayden DA, Barford D, Lorimer CG, Fothergill-Gilmore LA, Schiltz E, Schmitt W, (1986) The structure of cat muscle pyruvate kinase. EMBO J 5: 475-481.
27. Mukherjee J, Phillips JJ, Zheng S, Wiencke J, Ronen SM, Pieper RO, (2013) Pyruvate kinase M2 expression, but not pyruvate kinase activity, is up-regulated in a grade-specific manner in human glioma. PLoS ONE 8: e57610.
28. Noguchi T, Inoue H, Tanaka T, (1986) The M1- and M2-type isozymes of rat pyruvate kinase are produced from the same gene by alternative RNA splicing. J Biol Chem 261: 13807-13812.
29. Stammers DK, Muirhead H, (1977) Three-dimensional structure of cat muscle pyruvate kinase at 3-1 A resolution. J Mol Biol 112: 309-316.
30. Takenaka M, Noguchi T, Sadahiro S, Hirai H, Yamada K, Matsuda T, et al (1991) Isolation and characterization of the human pyruvate kinase M gene. Eur J Biochem 198: 101-106.
31. Vander Heiden MG, Cantley LC, Thompson CB, (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324: 1029-1033.
32. Vander Heiden MG, Plas DR, Rathmell JC, Fox CJ, Harris MH, Thompson CB, (2001) Growth factors can influence cell growth and survival through effects on glucose metabolism. Mol Cell Biol 21: 5899-5912.
33. Vaupel P, Kallinowski F, Okunieff P, (1989) Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 49: 6449-6465.
34. Wang YH, Israelsen WJ, Lee D, Yu VW, Jeanson NT, Clish CB, et al (2014) Cell-state-specific metabolic dependency in hematopoiesis and leukemogenesis. Cell 158: 1309-1323.
35. Warburg O, (1956) On the origin of cancer cells. Science 123: 309-314.
36. Warburg O, Wind F, Negelein E, (1924) Über den stoffwechsel der tumoren. Biochem Z 152: 319-344.
37. Weinberg F, Hamanaka R, Wheaton WW, Weinberg S, Joseph J, Lopez M, et al (2010) Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity. Proc Natl Acad Sci U S A 107: 8788-8793.
38. Weinberg SE, Chandel NS, (2015) Targeting mitochondria metabolism for cancer therapy. Nat Chem Biol 11: 9-15.
39. Yang W, Xia Y, Hawke D, Li X, Liang J, Xing D, et al (2012) PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis. Cell 150: 685-696.